Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo

Area of Science:

• Cell Biology
• Immunology
• Vascular Biology

Background:

• Circulating progenitor cells (CPC) are a heterogeneous group with potential for vascular repair.
• CPC are identified by markers like CD34, CD133, and VEGFR-2, often termed endothelial progenitor cells.
• The functional heterogeneity among CPC subsets based on single marker expression is not well understood.

Purpose of the Study:

• To investigate the functional heterogeneity of CPC subsets defined by CD34, CD133, and VEGFR-2 expression.
• To assess the capacity of CPC subsets to differentiate into endothelial cells.
• To evaluate the role of CPC subsets in vascular remodeling via inflammatory cell recruitment.

Main Methods:

• Established an in vivo model using Matrigel pellets with human CPC subsets transplanted into nude mice.
• Analyzed donor-derived neovascularization and host angiogenesis by examining capillary formation and CD31 expression.
• Quantified the recruitment of host monocytes/macrophages by different CPC subsets.

Main Results:

• Human CD34+ CPC contributed minimally to donor-derived neovascularization but strongly promoted host angiogenesis.
• CD133+ and VEGFR-2+ CPC subsets showed less impact on both donor neovascularization and host angiogenesis.
• CD34+ CPC were significantly more effective than CD133+ and VEGFR-2+ CPC in recruiting host monocytes/macrophages.

Conclusions:

• In this model, CD34+ CPC primarily act as regulators of host angiogenic and pro-inflammatory responses.
• These cells contribute marginally to neovascularization through direct differentiation.
• CD34+ CPC may play a crucial role in the remodeling of vascular lesions by modulating the inflammatory environment.